Abstract:The direct killing of cancer cells by cytotoxic T-lymphocytes (CTL) is critical for achieving effective antitumor immune responses. While several tumor-intrinsic mutations have been identified that promote evasion to CTL killing, there remains a paucity of data cataloging how individual genetic perturbations impact cancer cell fitness under immunotherapeutic selection pressure. Towards this, genetic screens using the CRISPR-Cas9 system have recently been employed, identifying novel intrinsic genetic regulators of cancer immunotherapy fitness. While these initial studies demonstrate the significant potential of unbiased genetic screens for discovery of novel immunotherapy targets, they have been limited in application to a small number of disease models. As such, the degree to which intrinsic genetic perturbations robustly modulate immunotherapy fitness across diverse cancer genotypes remains largely unexplored. To circumvent this knowledge gap, we performed genetic screens across a panel of commonly utilized syngeneic murine cancer cell lines to identify a core set of genes that render cancer cells more sensitive or resistant to CTL killing across diverse genetic backgrounds. An optimized genome-scale gRNA library targeting ~19,000 protein-coding genes in the murine genome (termed mTKO; mouse Toronto Knockout) was created in an analogous manner to our human library. Screens were performed in multiple murine cell lines engineered to express model tumor-associated antigens. Cells were propagated in the presence or absence of preactivated antigen-specific CTLs, and gRNA abundance was quantified by illumina sequencing to identify perturbed genes enriched or depleted in CTL treated versus untreated populations. These screens uncovered known genetic regulators of CTL killing including immune checkpoints (Cd274), antigen presentation machinery (B2m, Tap1/2) and interferon signaling components (Socs1, Jak1/2, Ifngr1/2), benchmarking the utility of this approach. Importantly, we leveraged this dataset to derive a core list of genes whose perturbation significantly modulates cancer-cell fitness to CTL killing across the majority of genotypes screened. Gene set enrichment analysis revealed critical roles for cytokine and TLR signaling, the NF-κB and MAPK pathways as well as the antiviral and antigen presentation machineries. As such, our dataset represents the first step towards a comprehensive understanding of the functional genomic landscape of CTL-mediated cytotoxicity. Citation Format: Keith Lawson, Xiaoyu Zhang, Cris Sousa, Rummy Akthar, Zi Fan, Eiru Kim, Medina Colic, Amy Tong, Katie Chan, Qian Huang, Xiaowei Wang, Kevin Brown, Michael Aregger, Antonio Finelli, Laurie Ailles, Traver Hart, Gillian Kingsbury, Charles Kung, Jason Moffat. Functional genomic landscape of T-cell mediated cytotoxicity [abstract]. In: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2018 Nov 27-30; Miami Beach, FL. Philadelphia (PA): AACR; Cancer Immunol Res 2020;8(4 Suppl):Abstract nr B60.

Elucidating Tumor Necrosis Factor Signaling Pathway Using A Functional Gene Identification Approach

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Functional genomic landscape of T-cell mediated cytotoxicity.

Integrative Computational Identifications of the Signaling Pathway Network Related to TNF-alpha Stimulus in Vascular Endothelial Cells

Detection of Differentially Expressed Genes in Two Cell Lines of NIH-3T3

Studies On The Apoptosis-Related Genes Of Tf-1 Cell Line By Cdna-Rda Technique.

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Expression and antitumor activity of retrovirus-mediated tumor necrosis factor a gene in human hepatocellular carcinoma cells

Genetic mapping of anti-apoptosis pathways in myeloid progenitor cells.

Reverse Genetics Applied to Immunobiology of Tumor Necrosis Factor, a Multifunctional Cytokine

Inhibitory Effect and Mechanism of Human Tumor Necrosis Factor-α Gene Transfected into Human Hepatoma Transplantation Tumor by LipofectamineTM 2000 in Nude Mice

Metaxin is required for tumor necrosis factor-induced cell death.

Endothelial cell-targeted expression of human tumor necrosis factor α mutant with higher activity from retroviral vectors

Identifying Tumor Promoting Genomic Alterations in Tumor-Associated Fibroblasts Via Retrovirus-Insertional Mutagenesis

Purification and functional analysis of human recombinant tumor necrosis factor-α

Functional Detection of TNF Receptor Family Members by Affinity-Labeled Ligands

Identification of Porcine Tumor Necrosis Factor-α (TNF-α) as the Target Gene of the miR-369

Extinction of the Tumor Necrosis Factor Locus, and of Genes Encoding the Lipopolysaccharide Signaling Pathway.

Regression of Tumors by IFN-α Electroporation Gene Therapy and Analysis of the Responsible Genes by Cdna Array

Nk Cell-Based Approach for Screening Novel Functional Immune Genes

Applying a New PCR Method to Quickly Prepare Human TNF-α Deletion Mutants